Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657031 · ClinicalTrials.gov registry record · Phase 4
The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
A Phase 4 study, sponsored by University Medical Center of Southern Nevada.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT02657031 is a Phase 4 study that has completed, run by University Medical Center of Southern Nevada. The registered enrollment target is 54 participants.
The verdict
NCT02657031, a Phase 4 study, has completed, sponsored by University Medical Center of Southern Nevada.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
This study compares the efficacy of low dose Ketamine versus Compazine for the control of headache in patients presenting to the Emergency Department.
Interventions
- DRUG Ketamine
- DRUG Ondansetron
- DRUG Diphenhydramine
- DRUG Normal Saline
- DRUG Prochlorperazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-03-17 |
| Est. Completion | 2017-03-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02657031
The ClinicalTrials.gov registry entry for NCT02657031 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Medical Center of Southern Nevada, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ketamine is the first listed.
NCT02657031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02657031 about?
NCT02657031 is a clinical study titled "The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine". This study compares the efficacy of low dose Ketamine versus Compazine for the control of headache in patients presenting to the Emergency Department.
What is the current status of trial NCT02657031?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2016-03-17. Estimated completion is 2017-03-21.
What interventions are being tested in trial NCT02657031?
The interventions under investigation include: Ketamine (DRUG), Ondansetron (DRUG), Diphenhydramine (DRUG), Normal Saline (DRUG), Prochlorperazine (DRUG).
Who is sponsoring clinical trial NCT02657031?
This trial is sponsored by University Medical Center of Southern Nevada, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.